>
HAVN Life Sciences Inc logo

HAVN - HAVN Life Sciences Inc Share Price

C$0.72 -0.0  -2.7%

Last Trade - 20/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £38.1m
Enterprise Value £30.5m
Revenue £n/a
Position in Universe 1020th / 2712
Bullish
Bearish
Unlock HAVN Revenue
Momentum
Relative Strength (%)
1m -0.070%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -51.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Apr 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 January 2021, HAVN LifeSciences Inc revenues was not reported. Net loss totaled toC$19.4M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HAVN Revenue Unlock HAVN Revenue

Net Income

HAVN Net Income Unlock HAVN Revenue

Normalised EPS

HAVN Normalised EPS Unlock HAVN Revenue

PE Ratio Range

HAVN PE Ratio Range Unlock HAVN Revenue

Dividend Yield Range

HAVN Dividend Yield Range Unlock HAVN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HAVN EPS Forecasts Unlock HAVN Revenue
Profile Summary

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the business of the research and development of psychopharmacological products, including the formulation of standardized psychoactive compounds derived from fungi. It operates through two divisions: HAVN Labs and HAVN Retail. HAVN Labs division is focused on development and formulation of regulated and novel psychoactive compounds. HAVN Retail division is focused on formulating and selling natural health products (NHPs) using compounds. The product lines of HAVN Retail include HAVN Immunity, HAVN Cognitive, HAVN Stress and HAVN Energy. Its formulations are being designed to target receptors and enzymes to support immune regulation, support the regulation and release of neurotransmitters that support mental cognition, to reduce stress response and to support mental energy.

Directors
Last Annual April 30th, 2020
Last Interim January 31st, 2021
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Canadian Securities Exchange
Shares in Issue 90,335,741
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HAVN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HAVN
Upcoming Events for HAVN
Frequently Asked Questions for HAVN Life Sciences Inc
What is the HAVN Life Sciences Inc share price?

As of 20/04/21, shares in HAVN Life Sciences Inc are trading at C$0.72, giving the company a market capitalisation of £38.1m. This share price information is delayed by 15 minutes.

How has the HAVN Life Sciences Inc share price performed this year?

Shares in HAVN Life Sciences Inc are currently trading at C$0.72 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the HAVN Life Sciences Inc price has moved by % over the past year.

What are the analyst and broker recommendations for HAVN Life Sciences Inc?

There are no analysts currently covering HAVN Life Sciences Inc.

When will HAVN Life Sciences Inc next release its financial results?

HAVN Life Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-31
What is the HAVN Life Sciences Inc dividend yield?

HAVN Life Sciences Inc does not currently pay a dividend.

Does HAVN Life Sciences Inc pay a dividend?

HAVN Life Sciences Inc does not currently pay a dividend.

When does HAVN Life Sciences Inc next pay dividends?

HAVN Life Sciences Inc does not currently pay a dividend.

How do I buy HAVN Life Sciences Inc shares?

To buy shares in HAVN Life Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of HAVN Life Sciences Inc?

Shares in HAVN Life Sciences Inc are currently trading at C$0.72, giving the company a market capitalisation of £38.1m.

Where are HAVN Life Sciences Inc shares listed? Where are HAVN Life Sciences Inc shares listed?

Here are the trading details for HAVN Life Sciences Inc:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: HAVN
What kind of share is HAVN Life Sciences Inc?

Based on an overall assessment of its quality, value and momentum, HAVN Life Sciences Inc is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a HAVN Life Sciences Inc share price forecast 2021?

We were not able to load any forecast data for HAVN Life Sciences Inc.

How can I tell whether the HAVN Life Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HAVN Life Sciences Inc. Over the past six months, the relative strength of its shares against the market has been -31.59%. At the current price of C$0.72, shares in HAVN Life Sciences Inc are trading at -14.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the HAVN Life Sciences Inc PE Ratio?

We were not able to find PE ratio data for HAVN Life Sciences Inc.

Who are the key directors of HAVN Life Sciences Inc?

We were unable to find the directors for HAVN Life Sciences Inc.

Who are the major shareholders of HAVN Life Sciences Inc?

Here are the top five shareholders of HAVN Life Sciences Inc based on the size of their shareholding:

Horizons Psychedelic Stock Index ETF Mutual Fund
Percentage owned: 2.42% (2.18m shares)
Horizons ETFs Management (Canada) Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.42% (2.18m shares)
Neufeld (Victor Rudolf) Individual Investor
Percentage owned: 0.89% (800k shares)
Staudt (Dennis Joseph) Individual Investor
Percentage owned: 0.11% (100.0k shares)
Leong (Gary Joseph) Individual Investor
Percentage owned: 0.09% (80.0k shares)
Similar to HAVN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.